icon

A New Class of Cancer Drugs May Be Less Toxic

December 05, 2020

An experimental treatment, called T-DM1, is a harbinger of a new class of cancer drugs that may be more effective and less toxic than many existing treatments. These laboratory-produced molecules mimic the antibodies made by a person’s immune system to fight infection. But instead of attacking pathogens these antibodies attach to specific proteins on the surface of cancer cells. “It’s almost like we’re masking the chemotherapy,” said Dr. Edith Perez, a breast cancer specialist at the Mayo Clinic in Jacksonville, Fla. Read more at http://www.nytimes.com/2012/06/01/business/a-new-class-of-cancer-drugs-may-be-less-toxic.html?_r=2&smid=tw-nytimes&seid=auto



Also in News

Guest Post: The Kindness Campaign discusses Skincare during Immunotherapy

January 04, 2022

Read More

Why does Lindi Skin contain fragrances?

December 01, 2021

Fragrance is one of the key decisions to be made when creating any skincare products, and our team of doctors, formulators and skincare experts created our formulas with very explicit instructions to design the products without any unnecessary fragrances, dyes, or ingredients.   

However, the key word here is “unnecessary”. 

Read More

"Be the solution" for a loved-one's skincare issues

November 16, 2021

Lindi Skin CEO Lindy Snider talks about how she created Lindi Skin because her friends could not find skincare to help with their skin issues from cancer treatments... and how you can help your loved ones by introducing them to Lindi Skin.

Read More

Liquid error: Could not find asset snippets/afterpay.liquid